Export rules affecting U.S. manufacturing of health technologies and policies affecting medical diagnostics, including cancer prevention
2026 · 3rd Quarter (July 1 - Sep 30)
WATERS CORP.
Filed by ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG).
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2026
- Income
- $80,000.00
- Expenses
- Not reported
- Client
- WATERS CORP.
- Filing UUID
- 12af97df-bc9f-430b-832f-4ac72282c454
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Export rules affecting U.S. manufacturing of health technologies and policies affecting medical diagnostics, including cancer prevention
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.